Patent · US Active

Cytochrome c acetylation

US7771961B2 · kind B2 · utility

0Cited by

0References

31Claims

0Family size

Assignee

ELIXIR PHARMACEUTICALS, INC. · US

Inventors

L. Julie Huber · Newton, US
Jonathan M. Solomon · Somerville, US

Key dates

Filing date	Jul 10, 2009
Grant date	Aug 10, 2010
Priority date	—
Expiry date	Jul 10, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2510/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Modulation of cytochrome c acetylation, e.g., with a SIR polypeptide, enables interventions that modulate lifespan regulation and cell proliferation, e.g., by modulating apoptosis and/or mitochondrial function such as respiration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.